3,966 Shares in Integer Holdings Co. (NYSE:ITGR) Acquired by Brucke Financial Inc.

Brucke Financial Inc. purchased a new position in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 3,966 shares of the medical equipment provider's stock, valued at approximately $564,000.

Other hedge funds also recently made changes to their positions in the company. Azzad Asset Management Inc. ADV grew its holdings in shares of Integer by 4.9% in the 4th quarter. Azzad Asset Management Inc. ADV now owns 12,138 shares of the medical equipment provider's stock valued at $1,609,000 after acquiring an additional 566 shares in the last quarter. Vise Technologies Inc. grew its stake in Integer by 8.3% in the fourth quarter. Vise Technologies Inc. now owns 4,702 shares of the medical equipment provider's stock valued at $623,000 after purchasing an additional 362 shares in the last quarter. Squarepoint Ops LLC increased its position in shares of Integer by 25.7% during the 4th quarter. Squarepoint Ops LLC now owns 3,162 shares of the medical equipment provider's stock worth $419,000 after purchasing an additional 646 shares during the last quarter. Teza Capital Management LLC raised its stake in shares of Integer by 11.6% during the 4th quarter. Teza Capital Management LLC now owns 2,727 shares of the medical equipment provider's stock worth $361,000 after purchasing an additional 284 shares in the last quarter. Finally, ProShare Advisors LLC boosted its holdings in shares of Integer by 44.4% in the 4th quarter. ProShare Advisors LLC now owns 10,051 shares of the medical equipment provider's stock valued at $1,332,000 after buying an additional 3,091 shares during the last quarter. 99.29% of the stock is owned by institutional investors.

Integer Stock Performance

Integer stock traded down $0.63 during trading hours on Friday, hitting $118.86. The company had a trading volume of 377,531 shares, compared to its average volume of 373,948. The firm has a 50-day moving average of $118.60 and a 200 day moving average of $128.63. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The firm has a market cap of $4.15 billion, a PE ratio of 35.38, a PEG ratio of 1.72 and a beta of 1.03. Integer Holdings Co. has a one year low of $104.93 and a one year high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last announced its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The company had revenue of $437.39 million for the quarter, compared to analyst estimates of $428.51 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. The firm's quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.14 earnings per share. On average, sell-side analysts expect that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Joseph W. Dziedzic sold 338,975 shares of the firm's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the transaction, the chief executive officer now owns 47,000 shares in the company, valued at approximately $5,788,990. This trade represents a 87.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.16% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities analysts recently weighed in on ITGR shares. Wall Street Zen upgraded shares of Integer from a "sell" rating to a "hold" rating in a report on Monday, May 19th. Benchmark lowered their price objective on shares of Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Raymond James upped their target price on shares of Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, April 25th. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and lifted their price target for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Finally, Truist Financial set a $150.00 price target on Integer and gave the stock a "buy" rating in a research report on Friday, April 25th. Two research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $145.00.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.